| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10834150 | Molecular Genetics and Metabolism | 2010 | 8 Pages |
Abstract
In summary, initial estimations of validity, reliability and feasibility for the new Fabry DS3 instrument suggest that it is a feasible and reliable means of assessing disease severity and progression over time and comparing inter-patient severity of Fabry disease. Our results demonstrate that the Fabry DS3 correlates highly with the clinical assessment by Fabry disease experts.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Edward H. Giannini, Atul B. Mehta, Max J. Hilz, Michael Beck, Daniel G. Bichet, Roscoe O. Brady, Michael West, Dominique P. Germain, Christoph Wanner, Stephen Waldek, Joe T.R. Clarke, Eugen Mengel, Jörg M. Strotmann, David G. Warnock, Ales Linhart,